CAD 1.7
(-2.86%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - CAD | 0.0% |
2022 | - CAD | -100.0% |
2021 | 1.00 CAD | 0.0% |
2020 | - CAD | 100.0% |
2019 | -264.96 Thousand CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 100.0% |
2014 | -40.67 Thousand CAD | -262.22% |
2013 | -11.23 Thousand CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | -100.0% |
2008 | 196.02 Thousand CAD | 8.41% |
2007 | 180.81 Thousand CAD | 10.61% |
2006 | 163.47 Thousand CAD | 270.66% |
2005 | 44.1 Thousand CAD | -8.08% |
2004 | 47.97 Thousand CAD | 0.69% |
2003 | 47.65 Thousand CAD | 0.0% |
2002 | - CAD | 0.0% |
2001 | - CAD | 0.0% |
2000 | - CAD | 0.0% |
1999 | - CAD | 0.0% |
1998 | - CAD | 0.0% |
1997 | - CAD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 32.19 Thousand CAD | 0.0% |
2024 Q2 | - CAD | 0.0% |
2024 Q1 | - CAD | 0.0% |
2023 Q4 | - CAD | 0.0% |
2023 FY | - CAD | 0.0% |
2023 Q2 | - CAD | -100.0% |
2023 Q1 | 1.00 CAD | 0.0% |
2023 Q3 | - CAD | 0.0% |
2022 Q1 | - CAD | -100.0% |
2022 Q4 | - CAD | 0.0% |
2022 FY | - CAD | -100.0% |
2022 Q2 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 Q3 | 1.00 CAD | 0.0% |
2021 Q4 | 1.00 CAD | 0.0% |
2021 FY | 1.00 CAD | 0.0% |
2020 Q3 | 15.85 Thousand CAD | -18.53% |
2020 FY | - CAD | 100.0% |
2020 Q1 | - CAD | 0.0% |
2020 Q2 | 19.45 Thousand CAD | 0.0% |
2020 Q4 | - CAD | -100.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 FY | -264.96 Thousand CAD | 0.0% |
2018 Q1 | 7000.00 CAD | -16.87% |
2018 FY | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2018 Q2 | - CAD | -100.0% |
2018 Q4 | - CAD | 0.0% |
2017 Q3 | 2971.00 CAD | -34.27% |
2017 Q1 | - CAD | -100.0% |
2017 Q2 | 4520.00 CAD | 0.0% |
2017 Q4 | 8421.00 CAD | 183.44% |
2017 FY | - CAD | 0.0% |
2016 Q4 | 760.00 CAD | -73.47% |
2016 Q3 | 2865.00 CAD | -43.92% |
2016 Q2 | 5109.00 CAD | 0.0% |
2016 Q1 | - CAD | -100.0% |
2016 FY | - CAD | 0.0% |
2015 Q3 | -24.34 Thousand CAD | 21.42% |
2015 Q4 | 540.00 CAD | 102.22% |
2015 Q1 | -55.48 Thousand CAD | -36.39% |
2015 Q2 | -30.98 Thousand CAD | 44.15% |
2015 FY | - CAD | 100.0% |
2014 Q1 | - CAD | 100.0% |
2014 Q4 | -40.67 Thousand CAD | -145.2% |
2014 Q3 | -16.58 Thousand CAD | 31.01% |
2014 Q2 | -24.04 Thousand CAD | 0.0% |
2014 FY | -40.67 Thousand CAD | -262.22% |
2013 Q4 | -11.23 Thousand CAD | -26.54% |
2013 FY | -11.23 Thousand CAD | 0.0% |
2013 Q3 | -8875.00 CAD | 11.25% |
2013 Q2 | -10 Thousand CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2009 FY | - CAD | -100.0% |
2009 Q1 | 196.02 Thousand CAD | 23.81% |
2009 Q2 | 67.25 Thousand CAD | -65.69% |
2009 Q4 | - CAD | 0.0% |
2009 Q3 | - CAD | -100.0% |
2008 FY | 196.02 Thousand CAD | 8.41% |
2008 Q1 | 180.81 Thousand CAD | -67.94% |
2008 Q2 | 357.91 Thousand CAD | 97.94% |
2008 Q3 | 263.71 Thousand CAD | -26.32% |
2008 Q4 | 158.32 Thousand CAD | -39.96% |
2007 Q3 | 2973.00 CAD | -94.36% |
2007 Q1 | 163.47 Thousand CAD | 108.09% |
2007 Q2 | 52.68 Thousand CAD | -67.77% |
2007 FY | 180.81 Thousand CAD | 10.61% |
2007 Q4 | 563.99 Thousand CAD | 18870.53% |
2006 FY | 163.47 Thousand CAD | 270.66% |
2006 Q4 | 78.55 Thousand CAD | 39.94% |
2006 Q3 | 56.13 Thousand CAD | -44.34% |
2006 Q2 | 100.85 Thousand CAD | 128.68% |
2006 Q1 | 44.1 Thousand CAD | 62.14% |
2005 Q4 | 27.2 Thousand CAD | 210.89% |
2005 Q3 | 8749.00 CAD | 67.22% |
2005 Q2 | 5232.00 CAD | -89.1% |
2005 Q1 | 47.97 Thousand CAD | -58.7% |
2005 FY | 44.1 Thousand CAD | -8.08% |
2004 Q3 | 78.48 Thousand CAD | 712.1% |
2004 Q1 | 47.65 Thousand CAD | 0.0% |
2004 Q2 | 9665.00 CAD | -79.72% |
2004 FY | 47.97 Thousand CAD | 0.69% |
2004 Q4 | 116.18 Thousand CAD | 48.03% |
2003 Q4 | - CAD | 0.0% |
2003 Q3 | - CAD | 0.0% |
2003 Q2 | - CAD | 0.0% |
2003 Q1 | - CAD | 0.0% |
2003 FY | 47.65 Thousand CAD | 0.0% |
2002 FY | - CAD | 0.0% |
2002 Q4 | - CAD | 0.0% |
2002 Q2 | - CAD | 0.0% |
2002 Q3 | - CAD | 0.0% |
2002 Q1 | - CAD | 0.0% |
2001 Q1 | - CAD | 0.0% |
2001 Q2 | - CAD | 0.0% |
2001 Q3 | - CAD | 0.0% |
2001 FY | - CAD | 0.0% |
2000 FY | - CAD | 0.0% |
2000 Q1 | - CAD | 0.0% |
1999 Q1 | - CAD | 0.0% |
1999 FY | - CAD | 0.0% |
1998 FY | - CAD | 0.0% |
1998 Q4 | - CAD | 0.0% |
1998 Q2 | - CAD | 0.0% |
1998 Q3 | - CAD | 0.0% |
1997 FY | - CAD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Covalon Technologies Ltd. | 5.94 Million CAD | 100.0% |
Hemostemix Inc. | - CAD | NaN% |
Universal Ibogaine Inc. | - CAD | NaN% |
Kane Biotech Inc. | 250.41 Thousand CAD | 100.0% |
MedMira Inc. | 182.42 Thousand CAD | 100.0% |
Marvel Biosciences Corp. | - CAD | NaN% |
NervGen Pharma Corp. | - CAD | NaN% |
XORTX Therapeutics Inc. | - CAD | NaN% |